documento - Plataforma de formación de SEPAR
documento - Plataforma de formación de SEPAR
documento - Plataforma de formación de SEPAR
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
74<br />
Bibliografía<br />
1. Jiménez Ruiz CA, De Granda Orive, Solano Reina S, Carrion Valero F Romero Palacios P, Barrueco Ferrero M. Normativa<br />
sobre el tratamiento <strong>de</strong>l tabaquismo. Sociedad Española <strong>de</strong> Neumología y Cirugía Torácica (<strong>SEPAR</strong>). Barcelona, 2002.<br />
2. Fiore MC, Bailey WC, Cohen SJ, Dorfman SF, Goldstein MG, Gritz ER et al. Treating tobacco use and <strong>de</strong>pen<strong>de</strong>nce. Clinical<br />
Practice Gui<strong>de</strong>line. Rockville, MD: US Department of Health and Human Services. Public Health Service, June 2000.<br />
3. Balfour D, Bates C, Benowitz N, Berridge V, Britton J, Callum C et al. Nicotine Addiction in Britain. A report the Tobacco<br />
Advisory Group of the Royal College of Physicians. Royal College of Physicians of London, 2000.<br />
4. JJ Lorza Blanco. Abordaje clínico terapéutico <strong>de</strong>l tabaquismo. En Solano Reina S y Jiménez Ruiz CA (Eds). Manual <strong>de</strong><br />
Tabaquismo (<strong>SEPAR</strong>). 2ª Edición, Editorial Masson 2002, pp 157-186.<br />
5. Silagy C, Lancaster T, Stead L, Mant D, Fowler G. Nicotine replacement therapy for smoking cessation. The Cochrane<br />
Library, nº 2. Oxford: Update Software, 2002.<br />
6. Tonnesen P, Paoletti P, Gustavsson G, Russell MA, Saracci R, Gulsvik A et al. Higher dosage nicotine patches increase oneyear<br />
smoking cessation rates : results from the European CEASE trial. Collaborative European Anti-Smoking Evaluation.<br />
European Respiratory Society. Eur Respir J 1999; 13 (2): 238-246.<br />
7. Schnei<strong>de</strong>r NG, Lunell E, Olsmtead RE, Fagerstrom KO. Clinical pharmacokinetics of nasal nicotine <strong>de</strong>livery: a review and<br />
comparison to other nicotine systems. Clinic Pharmacokinetic 1996; 31: 65-80.<br />
8. Shiffman S, Dresler CM, Hajek P, Gilburt SJ, Targett DA, Strash KR. Efficacy of a nicotine lozenge for smoking cessation.<br />
Arch Intern Med. 2002; 162 (11): 1267-1276.<br />
9. Ferry LH, Burchette RJ. Efficacy of bupropion for smoking cessation in on-<strong>de</strong>pressed smokers (abstract). J Addict Dis<br />
1994; 13: 249<br />
10. Ferry LH, Robbins AS, Scariatti PD et al. Enhancement of smoking cessation using the anti<strong>de</strong>pressant bupropion<br />
hydrochlori<strong>de</strong> (abstract). Circulation 1992; 86 (Suppl 1): 671.<br />
11. Hurt RD, Sachs DPL, Glober D et al. A comparison of sustained-release bupropion and placebo for smoking cessation.<br />
N Engl J Med 1997, 337: 1195-1202.<br />
12. Jorenby DE, Leischow SJ, Ni<strong>de</strong>s MA et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for<br />
smoking cessation. N Engl J Med 1999 ; 340: 685-691.<br />
13. Covey LS, Glassman AH. A meta-analysis of double-bind placebo-controlled trials of clonidine for smoking cessation. Br<br />
J Adict 1991; 86: 991-998.<br />
14. Hall SM, Reus VI, Muñoz F et al. Nortriptiline and cognitive-behavioral therapy for the treatment of cigarette smoking.<br />
Arch Gen Psychiatry 1998; 55: 683-690.<br />
Cursos <strong>de</strong> <strong>formación</strong> continuada